Related Experiment Video
Updated: May 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
[Meningococcal disease: always present. Serogroup changes in the Southern Cone]
Eduardo Luis López1, Roberto Debbag
1Sociedad Argentina de Infectología Pediátrica, Buenos Aires, Argentina. eduardoluislopez@fibertel.com.ar
Abstract:
Meningococcal disease (MD) caused by Neisseria meningitidis is a condition with high mortality rates in childhood. Serogroup W135 N. meningitidis (MenW135) is usually associated with 1 to 8% of MD cases worldwide, and with a low carriage rate. During March 2000, an increase in the number of cases of MenW135 in Saudi Arabia was reported that coincided with the Hajj pilgrimage (Hajj-2000 strain). Mayer et al studied MenW135 strains from outbreaks related with this pilgrimage and found that all had been caused by the same hypervirulent clone (ST-11/complex ET-37). The circulation of this strain could also be documented in Latin America. In the last years, changes in serogroup prevalence have been observed in the region, the increase of MenW135 in the Southern Cone being the most significant. N. meningitidis infections of several serogroups including MenW135 may be prevented with chemoprophylaxis with antibiotics and quadrivalent vaccines. Better knowledge of the global epidemiology through the new molecular techniques, jointly with the availability of vaccines are the most relevant tools to control hyperendemic or epidemic periods of MD.
Insights
Meningococcal disease (MD) outbreaks, particularly from the hypervirulent ST-11 clone of serogroup W135 Neisseria meningitidis, have emerged globally. Enhanced surveillance and vaccination are key to controlling this serious childhood illness.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Meningococcal disease (MD), caused by Neisseria meningitidis, presents high childhood mortality rates.
- Serogroup W135 N. meningitidis (MenW135) typically accounts for 1-8% of global MD cases with low carriage rates.
- An increase in MenW135 cases, linked to the Hajj pilgrimage (Hajj-2000 strain), was reported in Saudi Arabia.
Purpose of the Study:
- To analyze the epidemiology of hypervirulent MenW135 strains.
- To investigate the emergence and spread of the ST-11/complex ET-37 clone.
- To inform strategies for controlling meningococcal disease outbreaks.
Main Methods:
- Molecular typing of MenW135 strains from outbreaks.
- Tracking the global circulation of specific N. meningitidis clones.
- Reviewing serogroup prevalence changes in affected regions.
Main Results:
- MenW135 strains from the Hajj-2000 outbreak were identified as a single hypervirulent clone (ST-11/complex ET-37).
- This hypervirulent clone was also detected circulating in Latin America.
- Significant increases in MenW135 prevalence, particularly in the Southern Cone, have been observed.
Conclusions:
- The ST-11/complex ET-37 clone represents a significant threat for hyperendemic or epidemic MD periods.
- Chemoprophylaxis and quadrivalent vaccines are crucial for preventing N. meningitidis infections.
- Improved global epidemiological knowledge via molecular techniques and vaccine availability are vital for MD control.
Related Concept Videos
Bacterial Meningitis I: Introduction
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Encephalitis l: Introduction
Arboviral Encephalitis

